Somatotropin is a type of drug used as a medication against the
growth and regeneration among humans and also stimulates cell
reproduction. Deficiency of growth hormones is rising across the
globe. Advancements in technology including development of
recombinant human growth hormone by the major players is boosting the
growth of the somatotropin market. Moreover, the leading companies
are focusing on raising production capacity in order to increase
supply in rural areas. Somatropin is a recombinant form of growth
hormone and is provided only as a prescription drug for the treatment
of adult growth hormone and disorders related to child growth. In the
U.S., it is only available at a pharmacy store on physician’s
prescription. Physicians in the U.S. have begun to prescribe
somatotropin to older patients for some growth defects, but not to
healthy individuals.
Request Brochure for Detailed Analysis @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=43445
The global somatotropin drugs market can be segmented based on
product type, application, route of administration, and distribution
channel. In terms of product type, the global market can be
bifurcated into powder and solvent. Based on application, the global
somatotropin drug market can be classified into Turner’s syndrome,
growth hormone deficiency, Prader-Willi syndrome, chronic renal
insufficiency, idiopathic short stature, small for gestational age,
and others. The growth hormone deficiency segment is expected to
witness strong growth during the forecast period. Pituitary tumors,
metabolic abnormalities, and skeletal abnormalities are the primary
causes of growth hormone deficiency. Adults with growth hormone
deficiency are also increasingly taking growth hormone injections, as
these protect them from increased muscle mass, fractures, and also
reduce the risk of heart diseases.
In terms of route of administration, the global somatotropin drug
market can be categorized into intramuscular, intravenous, and
subcutaneous. The subcutaneous segment is likely to witness
substantial growth during the forecast period owing to significant
rise in growth rates and low incidence of antibody development.
Moreover, subcutaneous route is highly preferred for chronic growth
hormone therapy. Based on distribution channel, the global market can
be divided into hospital pharmacies, retail pharmacies, online
pharmacies, and clinics. Hospital pharmacies is likely to be the
largest distribution channel segment of the global somatotropin
market. This is attributed to high cost of human growth hormone
drugs. Moreover, high investment in the development of advanced
health care centers and hospitals by governments in various countries
drives the distribution of growth hormone drugs through hospital
pharmacies.
Enquire for Discount @
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=43445
Geographically, the somatotropin drug market can be segmented into
five major regions: North America, Middle East & Africa, Latin
America, Asia Pacific, and Europe. North America is the leading
market for somatotropin drug in terms of revenue, followed by Europe.
The U.S. held the largest share of the market in North America. Asia
Pacific and Latin America are emerging markets and are expected to
witness significant growth during the forecast period. High growth
rates in these regions are attributable to increase in number of
people having growth hormone deficiency. The somatotropin drug market
in countries such as China, India, and Brazil is projected to expand
at a rapid pace during the forecast period due to increase in
awareness among the population about growth hormone deficiency
treatment.
Major players operating in the global somatotropin drug market
include Merck KGaA, Eli Lilly and Company, Novo Nordisk A/S, Anhui
Anke Biotechnology Co., Ltd., Ipsen S.A., GeneScience Pharmaceuticals
Co., Ltd., Roche Holdings, Inc., Pfizer Inc., Novartis AG, and
Biopartners GmbH.
Request TOC of the Report for Complete Review @
https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=43445
About Us
Transparency Market Research is a next-generation market intelligence
provider, offering fact-based solutions to business leaders,
consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow,
evolve, and mature. Our real-time data collection methods along with
ability to track more than one million high growth niche products are
aligned with your aims. The detailed and proprietary statistical
models used by our analysts offer insights for making right decision
in the shortest span of time. For organizations that require specific
but comprehensive information we offer customized solutions through
adhoc reports. These requests are delivered with the perfect
combination of right sense of fact-oriented problem solving
methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems
with right methodology of research is the key to help enterprises
reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment